Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives, Eur Respir J, vol.53, p.1801887, 2019. ,
Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects, Hum Mutat, vol.36, pp.1113-1127, 2015. ,
Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases, Eur Respir J, vol.53, p.1801371, 2019. ,
TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension, J Med Genet, vol.50, pp.500-506, 2013. ,
Genetic analyses in a cohort of children with pulmonary hypertension, Eur Respir J, vol.48, pp.1118-1126, 2016. ,
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension, Nat Commun, vol.9, p.1416, 2018. ,
A novel channelopathy in pulmonary arterial hypertension, N Engl J Med, vol.369, pp.351-361, 2013. ,
Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension, Circ Cardiovasc Genet, vol.5, pp.336-343, 2012. ,
Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report, BMC Pulm Med, vol.16, p.17, 2016. ,
Genetics and genomics of pulmonary arterial hypertension, Eur Respir J, vol.53, p.1801899, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02137830
Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension, Eur Respir J, vol.53, p.1801609, 2019. ,
Vascular endothelial growth factor: basic science and clinical progress, Endocr Rev, vol.25, pp.581-611, 2004. ,
Deciphering mechanisms controlling placental artery endothelial cell migration stimulated by vascular endothelial growth factor, Endocrinology, vol.151, pp.3432-3444, 2010. ,
Vascular endothelial growth factor in the lung, Am J Physiol Lung Cell Mol Physiol, vol.290, pp.209-221, 2006. ,
Inhibition of angiogenesis decreases alveolarization in the developing rat lung, Am J Physiol Lung Cell Mol Physiol, vol.279, pp.600-607, 2000. ,
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension, Faseb J, vol.15, pp.427-438, 2001. ,
ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, vol.17, pp.405-424, 2015. ,
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor, Biochem Biophys Res Commun, vol.187, pp.1579-1586, 1992. ,
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells, EMBO J, vol.20, pp.2768-2778, 2001. ,
Mapping of the sites involved in ligand association and dissociation at the extracellular domain of the kinase insert domain-containing receptor for vascular endothelial growth factor, J Biol Chem, vol.273, pp.31283-31288, 1998. ,
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources, Am J Hum Genet, vol.84, pp.524-533, 2009. ,
Analysis of protein-coding genetic variation in 60,706 humans, Nature, vol.536, pp.285-291, 2016. ,
Reduced transfer coefficient of carbon monoxide in pulmonary arterial hypertension implicates rare protein-truncating variants in KDR, bioRxiv, 2019. ,
The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells, J Exp Med, vol.178, pp.2077-2088, 1993. ,
A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis, Cell, vol.89, pp.981-990, 1997. ,
VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung, Dev Dyn, vol.219, pp.341-352, 2000. ,
Tissue interactions mediate early events in pulmonary vasculogenesis, Dev Dyn, vol.217, pp.159-169, 2000. ,
Reduced gas transfer at rest and during exercise in school-age survivors of bronchopulmonary dysplasia, Am J Respir Crit Care Med, vol.157, pp.1406-1412, 1998. ,
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema, J Clin Invest, vol.106, pp.1311-1319, 2000. ,
Severe emphysema in the SU5416/hypoxia rat model of pulmonary hypertension, Am J Respir Crit Care Med, vol.200, pp.515-518, 2019. ,
BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension, Am J Hum Genet, vol.68, pp.92-102, 2001. ,
Heterozygous disruption of Flk-1 receptor leads to myocardial ischaemia reperfusion injury in mice: application of affymetrix gene chip analysis, J Cell Mol Med, vol.12, pp.1284-1302, 2008. ,
Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1), Sci Rep, vol.8, p.14724, 2018. ,
Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis, J Pathol, vol.195, pp.367-374, 2001. ,
,
Temporal hemodynamic and histological progression in Sugen5416/ hypoxia/normoxia-exposed pulmonary arterial hypertensive rats, Am J Physiol Heart Circ Physiol, vol.306, pp.243-250, 2014. ,
Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats, Am J Physiol Lung Cell Mol Physiol, vol.310, pp.1088-1097, 2016. ,
Vascular endothelial growth factor promotes physical wound repair and is anti-apoptotic in primary distal lung epithelial and A549 cells, Crit Care Med, vol.35, pp.2164-2170, 2007. ,
VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats, J Clin Invest, vol.119, pp.1298-1311, 2009. ,
Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, vol.53, p.1801913, 2019. ,
,